Series A - Resolution Therapeutics - 2022-04-05 - Crunchbase

Apr 5, 2022 · Resolution Therapeutics raised $13076904 on 2022-04-05 in Series A. Syncona Partners LLP Syncona Partners LLP is a healthcare company focused on investing in and …

CouponFollow Extension

$13076904
OFF

Series A - Resolution Therapeutics - 2022-04-05 - Crunchbase

6 days from now

Apr 5, 2022 · Resolution Therapeutics raised $13076904 on 2022-04-05 in Series A. Syncona Partners LLP Syncona Partners LLP is a healthcare company focused on investing in and …

crunchbase.com

£10
OFF

Resolution Therapeutics Announces A £10m Extended Series A …

6 days from now

Apr 5, 2022 · – Broadening research pipeline into allogeneic macrophages for the treatment of liver disease – London, 5 April 2022 – Resolution Therapeutics Limited (“Resolution”), a …

resolution-tx.com

£10
OFF

Resolution Therapeutics Announces A £10m Extended Series A

6 days from now

05.04.22. Share this page. Further reading ... 5 April, 2022 – Resolution Therapeutics Limited (“Resolution”), a biopharmaceutical company developing macrophage cell therapy to treat …

synconaltd.com

£26
OFF

Resolution Therapeutics Announces A £26.6m Series A ... - Syncona

6 days from now

May 6, 2024 · Resolution Therapeutics Limited (“Resolution”), a biopharmaceutical company developing macrophage cell therapy to treat chronic diseases characterised by life-threatening …

synconaltd.com

$13
OFF

Resolution Pads Series A, Adds Allogeneic Macrophage Cell Therapy ...

6 days from now

Apr 6, 2022 · Syncona Ltd. has added £10 million (US$13.1 million) to the £26.6 million it put into the series A round of Resolution Therapeutics Ltd., enabling the company to advance an …

bioworld.com

£63
OFF

Resolution Therapeutics Announces £63.5 Million Series B …

6 days from now

Mar 10, 2024 · Edinburgh and London, UK, 3 October 2024 – Resolution Therapeutics Limited (“Resolution”), a clinical-stage biopharmaceutical company focused on unlocking the …

synconaltd.com

$41063697
OFF

Series A - Domain Therapeutics - 2022-05-10 - Crunchbase

6 days from now

May 10, 2022 · Domain Therapeutics raised $41063697 on 2022-05-10 in Series A. Panacea Venture Panacea Venture is a healthcare-focused venture capital firm that focuses on …

crunchbase.com

$35559881
OFF

Series A - Resolution Therapeutics - 2020-12-02 - Crunchbase

6 days from now

Dec 2, 2020 · Resolution Therapeutics raised $35559881 on 2020-12-02 in Series A. Syncona Partners LLP Syncona Partners LLP is a healthcare company focused on investing in and …

crunchbase.com

$29147914
OFF

Series B - Resolution Therapeutics - 2024-10-03 - Crunchbase

6 days from now

Oct 3, 2024 · Resolution Therapeutics raised $29147914 on 2024-10-03 in Series B. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. Products. Resources. Pricing. …

crunchbase.com

FAQs about Series A - Resolution Therapeutics - 2022-04-05 - Crunchbase Coupon?

What's new in Resolution Therapeutics in 2022?

In 2022, Resolution Therapeutics announced a £10M Series A extension to broaden its research pipeline into allogeneic macrophages for the treatment of liver disease. ...

What is Resolution Therapeutics?

Resolution Therapeutics is a biotechnology company developing macrophage cell therapies to treat advanced liver disease. The Company has a decade-long history of research in the Founders’ laboratories characterising the role of macrophages in organ repair, including the liver, both in the pre-clinical and clinical settings. ...

What does Series A funding mean for Resolution?

This extended Series A funding for Resolution will enable the company to continue to develop its autologous macrophage cell therapies and broaden its research activity into the development of an allogeneic platform to produce ‘off-the-shelf’ macrophage cell therapies. ...